Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning The New York Times Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce Pharma Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits Oncodaily Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation Applied Clinical Trials Online